ORBIMED ADVISORS LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1055951 New York, NY

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,313,124

+$3,311,208 QoQ

Shares Held

1,737,287

+8.8% QoQ

Ownership

9.38%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 43.670792448225306.ToString("F0")% Shared 0.ToString("F0")% None 56.329207551774694.ToString("F0")%

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. CRBP ranks #39 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$488,832,498
2	ELVN	Enliven Therapeutics, Inc.	7,959,538	$312,013,889
3	SION	Sionna Therapeutics, Inc.	3,530,702	$141,545,843
4	MBX	MBX Biosciences, Inc.	3,637,887	$108,590,926
5	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$104,824,037
6	ARGX	Argenx SE	136,900	$99,971,225
7	CMPX	Compass Therapeutics, Inc.	15,219,994	$80,513,768
8	GPCR	Structure Therapeutics Inc.	1,475,403	$71,114,424

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,313,124	1,737,287	+8.8%	Shares	Defined	2026-05-15
2025-12-31	$13,001,916	1,597,287	+36.3%	Shares	Defined	2026-02-17
2025-09-30	$14,829,430	1,172,287	0.0%	Shares	Defined	2025-11-14
2025-06-30	$8,088,780	1,172,287	0.0%	Shares	Defined	2025-08-14
2025-03-31	$6,224,843	1,172,287	+63.2%	Shares	Defined	2025-05-15
2024-12-31	$8,474,760	718,200	-38.7%	Shares	Sole	2025-02-14
2024-12-31	$13,832,986	1,172,287	+28.5%	Shares	Defined	2025-02-14
2024-09-30	$18,825,947	912,552	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.